PoliticalRepoPoliticalRepo

United States · Bill · S

S. 1239 (111th)

340B Program Improvement and Integrity Act of 2009

referredUnited States· United States Congress· EN

Introduced

11 June 2009

Last action

11 June 2009 · Introduced

Status

Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (text of measure as introduced: CR S6546-6548)

Sponsors

Sen. Bingaman, Jeff [D-NM], John Thune, Kirsten Gillibrand, Sen. Inouye, Daniel K. [D-HI], Sen. Feinstein, Dianne [D-CA], Sen. Hagan, Kay R. [D-NC], Sen. Chambliss, Saxby [R-GA], Sheldon Whitehouse, Rep. Johnson, Tim [D-SD-At Large]

Subjects

Healthcare

Source updated

14 August 2025

Healthcare

Summary

340B Program Improvement and Integrity Act of 2009 - Amends the Public Health Service Act to expand the drug discount program to allow participation as a covered entity by certain: (1) children's hospitals; (2) critical access hospitals; and (3) rural referral centers. Expands the program to include drugs used in connection with an inpatient or outpatient service by enrolled hospitals (currently, only outpatient drugs are covered under the program). Prohibits enrolled hospitals from obtaining covered outpatient drugs through a group purchasing arrangement. Requires the Secretary of Health and Human Services (HHS) to establish reasonable exceptions to such prohibition, including for drugs unavailable through the program and to facilitate generic substitution when a generic covered drug is available at a lower price. Requires a hospital enrolled in the 340B drug discount program to issue a credit to a state Medicaid program for inpatient drugs provided to Medicaid recipients. Requires the Secretary to: (1) provide for improvements in compliance by manufacturers and covered entities with the requirements of the drug discount program; and (2) establish and implement an administrative process for resolving claims by covered entities and manufacturers of violations of such requirements. Requires manufacturers to offer each covered entity covered drugs for purchase at or below the applicable ceiling price if such a drug is made available to any other purchaser at any price.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

  1. 11 June 2009

    Introduced

    Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (text of measure as introduced: CR S6546-6548)

    Source: IntroReferral

  2. 11 June 2009

    Introduced

    Sponsor introductory remarks on measure. (CR S6546)

    Source: IntroReferral

  3. 11 June 2009

    Introduced

    Introduced in Senate

    Source: IntroReferral

Votes

No vote records are attached yet.

Versions

Documents

3 official files

Introduced in Senate (text)

View fileDownload file

Sponsors

Related records

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.